5-alpha Reductase

5-alpha Reductase, including 5-alpha Reductase type1, 5-alpha Reductase type2, and 5-alpha Reductase type3, is an isoenzyme which can convert testosterone to dihydrotestosterone. 5-alpha Reductase is related to prostate cancer, BPH and other cancer so that 5-alpha reductase can be a target of therapeutic intervention in both benign and cancerous diseases.

Cat.No. Product Name Information Product Use Citations Product Validations
S1202 Dutasteride Dutasteride (GI198745, GG-745) is a dual 5-α reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone (DHT).
Neoplasia, 2024, 57:101045
Food Chem Toxicol, 2023, 176:113764
Cancer Rep (Hoboken), 2021, e1418
S1197 Finasteride Finasteride (MK-906) is a potent, reversible inhibitor of the rat type 1 5 alpha-reductase with Ki of 10.2 nM, used in the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).
Biochem Pharmacol, 2025, 241:117171
Drug Des Devel Ther, 2025, 19:2393-2409
J Ethnopharmacol, 2024, 330:118227
S2283 Cinchonine(LA40221) Cinchonine (LA40221) is an alkaloid and a stereoisomer and pseudo-enantiomer of cinchonidine.
CNS Neurosci Ther, 2023, 10.1111/cns.14403
S2188 Phenprocoumon Phenprocoumon (Marcoumar, Marcumar and Falithrom,Ro 1-4849) is a vitamin K reductase with an IC50 of 1 μM
J Immunother Cancer, 2024, 12(11)e009805
S2345 Podophyllotoxin (Podofilox) Podophyllotoxin (Condylox,Podofilox) is a lignan (lignans) found in podophyllin resin from the roots of podophyllum plants.
S4593 Chlormadinone acetate Chlormadinone acetate (Gestafortin) is a steroidal progestin with additional antiandrogen and antigonadotropic effects, used often in combinations as an oral contraceptive. Its half-life is about 34-38 hours.

Signaling Pathway Map